Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |